MT1M and neoplasm: Taken together, the tumor suppressive mechanisms of GSTO2 and MT1M in these contexts suggest that p38, NF-kB, MDM2/p53, and SOD1/PI3K signaling may be contributing to aggressiveness in NKX3-1-loss tumors.